Navigation Links
Immediate risk of suicide and cardiovascular death after a prostate cancer diagnosis
Date:2/2/2010

Being diagnosed with prostate cancer may increase a man's risk of suicide or cardiovascular death, especially right after diagnosis, according to a new study published online February 2 in the Journal of the National Cancer Institute.

To study the risks men diagnosed with prostate cancer in the United States face, Fang Fang, M.D., of the Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, in Boston, and colleagues used data from over 340,000 prostate cancer patients listed in the Surveillance, Epidemiology, and End Results database between 1979 and 2004 and from the general population. The researchers compared risks in the first year and months after diagnosis.

According to the study, 148 men died of suicide (mortality rate = 0.5 per 1,000 person-years) and 6,845 died of cardiovascular diseases (mortality rate = 21.8 per 1000 person-years). Increased risk of suicide was found during the first year, in particular the first 3 months. The risk of cardiovascular death was slightly elevated during the first year, especially in the first month and particularly among those with metastatic disease.

According to the study, the elevated suicide risk was apparent before prostate-specific antigen (PSA) testing was common (1979�) and when it was first introduced (1987�), but not since PSA testing has been widespread (1993�). The authors say this observation is most likely due to the potentially lower degree of stress associated with the diagnosis of indolent prostate cancer.

"We believe that suicide and cardiovascular death reflect only the tip of the iceberg of anxiety, mood disturbance, and perhaps other mental illness (or suffering) after a prostate cancer diagnosis," the authors write. "Hence, our study suggests the potential importance of providing emotional counseling and support for patients newly diagnosed with cancer. It also adds to the increasingly complex scenario of pros and cons of extensive PSA testing, which entails detection of large numbers of nonlethal prostate cancers."


'/>"/>

Contact: Steve Graff
jncimedia@oxfordjournals.org
301-841-1285
Journal of the National Cancer Institute
Source:Eurekalert

Related medicine news :

1. The Salvation Army Responds to Immediate Needs of Survivors and Relief Workers in Southern California Wildfires
2. King Pharmaceuticals and Acura Pharmaceuticals Enter Agreement to Develop and Commercialize Immediate Release Pain Medicines Utilizing Acuras Aversion(R) (Abuse-Deterrent) Technology
3. ISPA Issues Immediate Recall of 2007 Global Consumer Studies
4. First Cognitive Training to Demonstrate Immediate Generalizability Through Standardized Assessments of Memory
5. Stroke study to add patients who cannot give immediate consent
6. Manor Care Files Motion with West Virginia Health Care Authority to Dissolve Stay and Issue an Immediate Ruling
7. Statement by American Heart Association Immediate-Past President Raymond Gibbons, M.D. on Congressional Omnibus Spending Bill
8. New Drug Application Submitted to FDA for Investigational Analgesic Tapentadol Immediate Release Tablets
9. Health Capital Group Warns of Fallout to Hospitals From the Subprime Mortgage Crisis and Urges Hospitals to Immediately Reassess Existing Debt Structures and Capital Financing Plans
10. Hondros College Expands School of Nursing to Columbus and Dayton; Students Can Begin LPN Education Almost Immediately
11. NAA Calls for Immediate Recall of All Mercury-Containing Vaccines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... ... September 22, 2017 , ... After a long health ordeal ... new lease on life with assistance from CreditAssociates. CreditAssociates provides debt relief and ... unsecured debt. The senior is one of the satisfied clients who expressed their ...
(Date:9/22/2017)... ... September 22, 2017 , ... SABRE ... Scholarship Sweepstakes.,  , Molli C., a graduate student from Sonora, California, who will ... Administration at St. Thomas University in Miami, Florida, was selected from a pool ...
(Date:9/22/2017)... Chicago, IL (PRWEB) , ... September 22, 2017 , ... ... founding attorney Richard L. Pullano has been selected to serve as President ... Association’s 50th President at the Installation and Award Dinner hosted by the NSBA at ...
(Date:9/22/2017)... ... September 22, 2017 , ... ... supplement produced by Native Remedies that helps promote pancreatic health and regulate ... individuals. However, some prescription-based approaches can have negative side effects, and with the ...
(Date:9/22/2017)... ... September 22, 2017 , ... "Success ... the world of Alzheimer’s. Alzheimer’s is a disease estimated to affect the lives ... information published by the Alzheimer’s Association, a leading voice in the fight for ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... NuvoAir (formerly called Pond Healthcare Innovation), the company ... Novartis Pharma AG to distribute NuvoAir,s spirometry technology to physicians ... spirometry platform and Novartis, commitment to address the unmet medical ... ... "We ...
(Date:9/6/2017)... 2017  Medical professionals are expected to ... treating their patients. Medical simulations offer clinicians ... patients. Simulation provides a safe method for ... procedures, refine techniques and build confidence, without ... technology, such as augmented reality, will now ...
(Date:9/5/2017)... KEYSTONE, Colo. , Sept. 5, 2017 ... their XR-29 DoseCheck solution. Scannerside DoseCheck is a third-party ... update existing CT scanners and allows compliance with current ... The Sapheneia-Scannerside proprietary XR 29 DoseCheck solution is specifically ... notifications and alerts of potential radiation doses over a ...
Breaking Medicine Technology: